Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 36 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7205327

    Imidazole and benzimidazole caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 17, 2007 · Expires Apr 12, 2027

    granted
  2. US 7205305

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Apr 17, 2007 · Expires Apr 12, 2027

    granted
  3. US 7186737

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2007 · Expires Mar 1, 2027

    granted
  4. US 7183307

    Pyrazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 27, 2007 · Expires Feb 22, 2027

    granted
  5. US 7179826

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 20, 2007 · Expires Feb 15, 2027

    granted
  6. US 7169798

    Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2007 · Expires Jan 25, 2027

    granted
  7. US 7169800

    Imidazole compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2007 · Expires Jan 25, 2027

    granted
  8. US 7169779

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2007 · Expires Jan 25, 2027

    granted
  9. US 7157476

    Aminofurazan compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 2, 2007 · Expires Dec 28, 2026

    granted
  10. US 7151101

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  11. US 7122552

    Inhibitors of JAK and CDK2 protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  12. US 7115637

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  13. US 7115739

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  14. US 7115746

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  15. US 7109215

    Compounds possessing neuronal activity

    Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2006 · Expires Sep 14, 2026

    granted
  16. US 7109172

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2006 · Expires Sep 14, 2026

    granted
  17. US 7105546

    Acyclic and cyclic amine derivatives

    Vertex Pharmaceuticals Incorporated · Granted Sep 12, 2006 · Expires Sep 7, 2026

    granted
  18. US 7098330

    Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 29, 2006 · Expires Aug 24, 2026

    granted
  19. US 7091343

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2006 · Expires Aug 10, 2026

    granted
  20. US 7087603

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 8, 2006 · Expires Aug 3, 2026

    granted
  21. US 7087642

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 8, 2006 · Expires Aug 3, 2026

    granted
  22. US 7084159

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 1, 2006 · Expires Jul 27, 2026

    granted
  23. US 7078209

    CAK inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  24. US 7074782

    Carbamate caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted